Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

American crackdown on opioids

- Featured Image

The United States Senate has overwhelmingly approved a string of bills aimed at fighting head-on America’s opioid epidemic.

The far-reaching legislative package had bipartisan support and was passed 99-1.

Republican Senator Mike Lee from Utah was the only one to vote against it.

The House of Representatives passed similar legislation in June, with both houses of Congress now taking direct aim at the opioid crisis.

The Senate’s Opioid Crisis Response Act of 2018 directs funding to federal agencies to establish or expand programs dealing with prevention, treatment and recovery.

The 70 bills in the package include the Trafficking and Overdose Prevention Act ‘STOP’ Act, which was endorsed by President Donald Trump.  It sets up a framework to stop shipments of fentanyl, a synthetic opioid, from entering the States.

Other bills include requiring the Food and Drug Administration to give prescription opioid pills in smaller quantities, and funding to the National Institutes of Health to develop of non-addictive painkillers.

Opioid overdose deaths in America in 2017 is estimated at 72,000.